Franetic Mentions First Insight | Smart Imitation Packaging for OTC Drugs: A Mistake?
The Allure of “Smart Imitation”
First Insight’s survey involving 1,267 US consumers revealed a striking trend: 44% are more inclined to try a private label product marketed as a “dupe” of a high-end product. This insight reveals a critical understanding of consumer behavior:
- Value for Money: Shoppers are on the lookout for options that provide quality without emptying their wallets.
- Brand Recognition: Imitating successful national brands plays into consumer familiarity, leading to quicker purchase decisions.
Read the full article on Franetic.
